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Above: Structural representations of a monomeric subunit of SOD1. Figure 1a shows a 
two-dimensional representation of the secondary structure of SOD1. Known mutation 
points are marked and each β-sheet and Loop is shown in a distinct color. The Zinc-
Loop is shown in Teal and the Electrostatic-Loop I shown in Violet. Figure 1b shows 
the three-dimensional representation of Figure 1a. The Zinc ion is shown as a grey 
sphere and the Copper ion is shown as a green sphere. Reprinted from Valentine et al 
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Figure 2: Crosslinked SOD1 Gels 
Figure 2a: Crosslinked SOD1 [20 µM] using EDC [200 µM] with Sulfo-NHS [50 µM]. 
Samples were quenched with ß-mercaptoethanol [20 µM final] at 15 minute intervals 
after addition of EDC + Sulfo-NHS in lanes 1, 2, 3, 4, 5, and 6. Lane 7 contains 
crosslinker, buffer and no protein. Figure 2b: Same EDC with Sulfo-NHS concentrations 
as in 3a and an increased SOD1 [30 µM] amount. No crosslinking seen at all. Figure 2c: 
Samples of SOD1 [20 µM] crosslinked with Glutaraldehyde 1% V/V (left two lanes) and 
EDC with Sulfo-NHS (right two lanes). Uncross linked SOD1 in middle lane. Figure 2d: 
SOD1 [20 µM] crosslinked with Glutaraldehyde and quenched with Tris buffer at 15 
minute intervals in Lanes 2, 3, 5, 6, & 7. Lane 1 MW Marker. Lane 4 uncrosslinked 
SOD1. Figure 4e: Crosslinked SOD1 [20 µM] after crosslinked with various 






















Figure 3: 90° Light Scattering data of AS-SOD1 aggregation. Top Graph: SOD1 
aggregation induced by raising temperature at 60º C. Bottom Graph: SOD1 aggregation 
induced by 15% V/V TFE and pH of 5.5 (in grey) and raising the temperature to 50°C 



















Figure 4: Gel showing the typical results of crosslinking SOD1 aggregates. 
Characteristic qualities to be noted: lack of discrete band patterns, uneven 
length of progression through the gel, and unexplained blots of low MW. 
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